Current Drug Targets - Cardiovascular & Hematological Disorders
Title: subject Index To Volume 2
Volume: 3 Issue: 1
Author(s): Bentham Science Publishers
Affiliation:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , subject Index To Volume 2, Current Drug Targets - Cardiovascular & Hematological Disorders 2003; 3 (1) . https://dx.doi.org/10.2174/1568006033337410
DOI https://dx.doi.org/10.2174/1568006033337410 |
Print ISSN 1568-0061 |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-0061 |
12
Related Articles
-
Determination of Lipoic Acid in the form of 2-S-pyridinium Derivative by High-performance Liquid Chromatography with Ultraviolet Detection
Current Analytical Chemistry Immobilization of Heparin: Approaches and Applications
Current Topics in Medicinal Chemistry Pregabalin Ameliorates Lipopolysaccharide-Induced Pancreatic Inflammation in Aged Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Monoclonal Antibody Therapies Targeting Pancreatic Ductal Adenocarcinoma
Current Drug Discovery Technologies Pharmaceutical Strategies for Activating Sirtuins
Current Pharmaceutical Design Why Does Obesity Increase the Risk for Cardiovascular Disease?
Current Pharmaceutical Design Physical Inactivity is Liable to the Increased Cardiovascular Risk and Impaired Cognitive Profile
Current Alzheimer Research Intestinal Permeability as a Clinical Surrogate Endpoint in the Development of Future Crohn's Disease Therapies
Recent Patents on Inflammation & Allergy Drug Discovery Revascularization vs. Optimal Medical Therapy in Women with NSTE-ACS
Current Pharmaceutical Design Interleukin-18, From Neuroinflammation to Alzheimers Disease
Current Pharmaceutical Design Drug Targeting to the Brain - A Review
Current Nanoscience Comprehensive Evaluation and Clinical Application of Combined Redox Assay Methods to Determine Total Antioxidant Capacity
Current Analytical Chemistry Adverse Reactions and Pathogen Safety of Intravenous Immunoglobulin
Current Drug Safety Stem Cell Therapy and Immunological Rejection in Animal Models
Current Molecular Pharmacology Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Inflammatory Pain: The Cellular Basis of Heat Hyperalgesia
Current Neuropharmacology Ovarian Aging: Melatonin Regulation of the Cytometric and Endocrine Evolutive Pattern
Current Aging Science Neuropeptide - Adipose Tissue Communication and Intestinal Pathophysiology
Current Pharmaceutical Design Corrigendum to: The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Genetic Alterations in Differentiated Thyroid Cancers
Endocrine, Metabolic & Immune Disorders - Drug Targets